Clawbacks — Another Source of Prescription Cost Overpayment

Brand and Generic drug prices show different pricing behaviors. In brand drugs, we see the effects of the 20 years of monopoly protection accorded to the first patent holder. However, the 20 years starts when the drug is invented, not when the FDA authorizes it for public use. Usually brand drugs are affordable despite noticeably […]